Month: October 2016

Medicine is a multinational industry no longer defined by country boundaries. Its main product is a workforce. Like the other major product, pharmaceuticals, clinicians are highly regulated and competitively priced. Unlike pharma however, the “product” has not evolved nor are there a succession of new and better models on the market. Postgraduate medical training is […]

As medicine becomes more complex and the dictionaries of disease become libraries, it’s time for us to change our clinical language. We have a duty to explain the complexities of our treatments to payers, patients and communities in the simplest, most understandable and up-to-date way possible. Some diseases have the audacity to remit and then […]